SCHEMBL7495976

SCHEMBL7495976

Cc1nn(-c2ccccc2)c(=O)c2c1c1c(Br)cccc1n2C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 1/20 0.44
CCNB1 P14635 1/20 0.44
CCNE1 P24864 1/20 0.44
CDK2 P24941 1/20 0.44
CA12 O43570 3/20 0.43
CA9 Q16790 3/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
HPGD P15428 2/20 0.41
MAPK1 P28482 1/20 0.41
ADORA3 P0DMS8 1/20 0.41
ALDH1A1 P00352 3/20 0.40
HSD17B10 Q99714 1/20 0.40
KMT2A Q03164 1/20 0.40
KDM4E B2RXH2 1/20 0.40
GSK3B P49841 1/20 0.40
RXFP1 Q9HBX9 1/20 0.39
TNF P01375 1/20 0.39
ATM Q13315 1/20 0.39
NOD2 Q9HC29 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7497735 0.84 TSPO (0.43) NPC1RAB9AHPGDMAPK1ADORA3
SCHEMBL7751594 0.81 TSPO (0.50) HPGDMAPK1ALDH1A1HSD17B10KMT2A
SCHEMBL7498246 0.80 KDM4E (0.42) CCNE1CDK2MAPK1ADORA3ALDH1A1
SCHEMBL7496512 0.78 TSPO (0.47) HPGDMAPK1ALDH1A1HSD17B10KMT2A
SCHEMBL7494763 0.76 TSPO (0.45) HPGDMAPK1ALDH1A1HSD17B10KMT2A
SCHEMBL16726611 0.69 CA12 (0.58) CDK1CCNB1CCNE1CDK2CA12
SCHEMBL14101694 0.68 NPSR1 (0.49) ADORA3ALDH1A1HSD17B10KMT2ARXFP1
SCHEMBL21975440 0.68 GPR3 (0.44) NPC1RAB9AALDH1A1HTT
SCHEMBL4117997 0.67 CYP1A2 (0.44) CA12CA9NPC1RAB9AHPGD
SCHEMBL15871239 0.67 ADORA3 (0.53) CDK1CCNB1CCNE1CDK2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1000063-B1 4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b]INDOLE-1-ACETAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPY SANOFI SYNTHELABO (FR) 2002-10-23 EP disclosed
US-6262045-B1 TREATMENT OF ANXIETY; SLEEP DISORDER; EPILEPSY; SPASTICITY; MUSCLE CONTRACTURE OR AN EXTRAPYRAMIDAL SYNDROM; INDUCING OR MAINTAINING ANAESTHESIA SANOFI-SYNTHELABO (FR) 2001-07-17 US disclosed